Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 10.35p on 18-07-2025 at 18:25:10
Change 0.00p 0%
Buy 11.00p
Sell 9.70p
Buy / Sell SCLP Shares
Last Trade: Sell 54,699.00 at 10.225p
Day's Volume: 500,421
Last Close: 10.35p
Open: 10.35p
ISIN: GB00B63D3314
Day's Range 10.35p - 10.35p
52wk Range: 7.25p - 19.50p
Market Capitalisation: £107.31m
VWAP: 10.25038p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 54,699 10.225p Ordinary
15:25:42 - 18-Jul-25
Sell* 14,666 10.20p Ordinary
13:55:21 - 18-Jul-25
Sell* 8,205 10.225p Ordinary
13:42:46 - 18-Jul-25
Sell* 9,668 10.25p Ordinary
11:53:28 - 18-Jul-25
Buy* 453 11.00p SI Trade
11:26:03 - 18-Jul-25
Sell* 524 9.70p SI Trade
11:26:03 - 18-Jul-25
Sell* 350 9.70p SI Trade
11:26:03 - 18-Jul-25
Sell* 100 9.70p SI Trade
11:26:03 - 18-Jul-25
Sell* 100,000 10.275p Ordinary
10:26:35 - 18-Jul-25
Unknown* 200,000 10.275p Ordinary
10:25:54 - 18-Jul-25
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Jul 2025 (Fri) 10.35 10.35 10.35 10.35 500,421
17th Jul 2025 (Thu) 10.25 10.35 10.25 10.35 1,191,009
16th Jul 2025 (Wed) 10.25 10.25 10.25 10.25 272,671
15th Jul 2025 (Tue) 10.25 10.40 10.25 10.25 276,904
14th Jul 2025 (Mon) 10.25 10.25 10.00 10.25 443,121
11th Jul 2025 (Fri) 10.00 10.25 10.00 10.25 409,597
10th Jul 2025 (Thu) 10.00 10.00 10.00 10.00 3,831,757
9th Jul 2025 (Wed) 10.00 10.00 10.00 10.00 191,327
8th Jul 2025 (Tue) 9.75 10.40 10.40 10.40 319,270
7th Jul 2025 (Mon) 10.00 10.00 9.75 9.75 1,285,008
4th Jul 2025 (Fri) 9.50 10.00 9.50 9.75 815,637
3rd Jul 2025 (Thu) 9.50 10.00 9.50 9.50 372,253
2nd Jul 2025 (Wed) 9.50 9.50 9.50 9.50 81,747
1st Jul 2025 (Tue) 9.50 9.50 9.50 9.50 358,815
30th Jun 2025 (Mon) 9.50 9.50 9.50 9.50 465,371
27th Jun 2025 (Fri) 9.25 9.50 9.25 9.50 794,670
26th Jun 2025 (Thu) 9.75 9.75 9.25 9.25 718,559
25th Jun 2025 (Wed) 10.25 10.25 9.75 9.75 661,835
24th Jun 2025 (Tue) 9.40 9.775 9.40 9.775 808,910
23rd Jun 2025 (Mon) 9.40 9.50 9.50 9.50 32,683
20th Jun 2025 (Fri) 9.90 9.775 9.40 9.40 716,493
19th Jun 2025 (Thu) 9.775 9.775 9.775 9.775 33,993
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
16th Jul 2025 7:00 am RNS Share Option Exercise
25th Jun 2025 7:00 am RNS Scancell initiates new arm in SCOPE Phase 2 study
21st May 2025 7:00 am RNS Director Dealing
14th Apr 2025 7:00 am RNS Partnership with NHS Cancer Vaccine Launch Pad
1st Apr 2025 7:00 am RNS Scancell to present at 2025 AACR Annual Meeting
20th Feb 2025 7:00 am RNS Issue of share options
17th Feb 2025 7:00 am RNS Scancell presenting at AACR IO conference
30th Jan 2025 7:00 am RNS Interim Results
23rd Jan 2025 7:00 am RNS Notice of Interim Results
9th Jan 2025 7:00 am RNS Modi-1 Vaccine Achieves Early Clinical Validation
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

LONDON MARKET MIDDAY: Stocks up, China warns on British Steel dispute

14th Apr 2025 11:47

(Alliance News) - Stock prices in London were in the green at midday on Monday, while Beijing has warned the UK against "politicising" an unfolding spat over the future of Chinese-owned British Steel. Read More

AIM WINNERS & LOSERS: Scancell in partnership with NHS 'Launch Pad'

14th Apr 2025 10:08

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

30th Jan 2025 19:54

Scancell Holdings PLC - Oxford, UK-based pharmaceutical firm - Pretax loss multiplies to GBP13.8 million in the six months to October 31 from GBP3.6 million a year prior. R&D expenses rise to GBP8.0 million from GBP5.7 million, administrative expenses edge up to GBP2.5 million from GBP2.4 million. Bottom line hit by GBP4.5 million loss relating to revaluation of derivative liability compared to GBP4.9 million gain a year prior. Cash balances at October 31 are GBP9.1 million compared to GBP14.8 million at April 30, 2024. Sees cash runway to the second half of 2026 beyond multiple clinical milestones. Read More

UK earnings, trading statements calendar - next 7 days

23rd Jan 2025 17:08

Read More

See more Scancell Holdings news
FTSE 100 Latest
Value8,992.12
Change19.48

Login to your account

Forgot Password?

Not Registered